Skip to main content
Evidence-led patent and technology research

Basf Pharma Callanish Limited Received A Patent For Multi Step Separation Process

The historical WordPress article attributes Indian application 5690/DELNP/2015 and reported patent 317312 to BASF Pharma (Callanish) Limited for a multi-step separation process. The technical account describes purification of polyunsaturated fatty acids through sequential chromatography with differing solvent systems. These are useful archival pointers, but the complete granted claims, family relationship and current Indian status must be checked against the patent record before treating the claimed process as a subsisting right.

Save or follow this source
These actions open third-party AI services. Saving, citation, and future recall are not guaranteed.
GIPResearch illustration supporting Basf Pharma Callanish Limited Received A Patent For Multi Step Separation Process
Research focusEvidence before conclusions

Identify source documents and material limitations relevant to the subject.

Decision contextClarify the technical question

Compare the available information with the specific invention or platform facts.

Research outputTraceable next steps

Document what is supported, uncertain or requires specialist analysis.

Substantive research and evidence

Basf Pharma Callanish Limited Received A Patent For Multi Step Separation Process — research analysis

Verification alert: P0: exact granted process claim, status and applicant chain unverified.

Applicant and patent family identity

A reliable file starts with bibliographic reconciliation. Match Indian national-phase filing details to the original PCT application, earliest priority, applicant name and title. The word 'Callanish' may appear in a corporate or family history and should not substitute for an official applicant/assignment chain. Compare publication claims with grant claims and record whether claims were restricted during examination. Without the corrected family tree, an analyst could compare the wrong patent in another jurisdiction or attribute a company's historical process to its current portfolio. Evidence checkpoint: Connect Indian application 5690/DELNP/2015 with the correct PCT family and final national grant; save ownership evidence separately. The record should include its issuing body, date, context and exact language. Where sources diverge, identify the conflict before converting this observation into a technical or legal conclusion.

Process inputs and ordered steps

The article describes a feed containing polyunsaturated fatty acids, a first chromatographic purification step and a second step employing a different aqueous organic solvent. A process claim can depend on order, solvent identity, polarity-index difference, excluded fractions and recovery characteristics. Draw a material-flow chart showing inputs, intermediate stream, fractions and outputs. Do not paraphrase a long dependent-claim exclusion as though it were merely background: exclusions may be central to the claim boundary. The original article's process description remains provisional until compared with the actual specification. Evidence checkpoint: Extract every independent-claim separation step and any expressly excluded fatty-acid products, solvents or numerical ranges. Compare the result with a plausible alternative explanation, since similarity of terms is not proof of equivalence. A reviewer should be able to repeat the comparison using the same underlying material.

Separation mechanism

Separation effectiveness requires measurable evidence. Potential questions include target purity, recovery, solvent use, column loading, reproducibility and impurity control. The prior account identifies a polarity-index interval as an alleged differentiator; whether that numerical limitation appears in the granted independent claim must be confirmed. A laboratory example demonstrating one feedstock cannot establish broad industrial performance for every fatty-acid mixture. Research should also distinguish patentable process configuration from unclaimed manufacturing know-how and equipment capabilities. Evidence checkpoint: Test whether polarity differences, feed composition and recovery data actually support the claimed industrial distinction. Retain the actual technical document or contractual clause supporting the finding. The decision-maker needs to know whether this is a binding limitation, a design option, or an unsupported assertion.

Visual framework for Basf Pharma Callanish Limited Received A Patent For Multi Step Separation Process
Analytical illustration — use source documents for the underlying facts.

Claim scope and dependent variations

The old article summarizes a section 3(d) objection and the applicant's response that the particular two-step solvent combination was not previously taught. A procedural-history analysis must retrieve the examiner's full objection, cited documents, amendments and final order. Section 3(d) should not be reduced to a generic rule that 'known processes cannot be patented'; its wording and the relevant claimed subject must be analyzed. Comparing what was initially claimed with what ultimately survived will identify the actual legal point, if any, resolved during examination. Evidence checkpoint: Read the section 3(d) exchange in full instead of treating the WordPress paraphrase as the patent office's decision. Record both supporting and adverse materials. An unexplained gap or contradiction is a reason to narrow the claim, not to add confident wording to an informational webpage.

Status and maintenance

Legal status is a dated question. Check the Indian register for grant details, annual renewal history, recorded ownership, lapse, restoration, expiry and proceedings; inspect other family jurisdictions separately. Even a live Indian process patent would not automatically stop an operator using a different sequence that omits a required limitation. Conversely, a narrowly scoped process claim can be significant for a specific commercial purification workflow. No freedom-to-operate conclusion is possible from the archive alone. Evidence checkpoint: Confirm a dated status including annuities and amendments in India; do not infer rights from other family members. Use a source date and relevant geography when the legal or operational position can change. An old document may be valuable history but should not be presented as a current certification.

Competing process literature

Compare the claimed chromatography arrangement with earlier simulated moving-bed separations, sequential purification processes, solvent-gradient methods and fatty-acid fractionation literature. The relevant comparison is not 'two steps versus one step' in isolation. Ask whether the cited art disclosed the same functional combination, solvent selection and result for a corresponding feed. Search records should capture priority dates and experiment conditions. A meaningful technical contribution must be tied to a claim limitation and supporting evidence rather than the presence of a sophisticated process diagram. Evidence checkpoint: Compare earlier two-stage chromatography and simulated moving-bed patents using identical process criteria and verified priority dates. Connect the outcome to a concrete next action: search a claim, change a document, test a control or ask for specialist review. A general statement of importance is not enough.

Original analytical framework and decision implications

The research matrix will align each step with the alleged claim limitation, supporting patent passage, documented process output, prior-art comparator and unresolved data. A second original artifact is a claim-history tracker recording each amendment and response to the section 3(d) objection, once files are obtained. Both matrices retain an explicit 'unverified' column until the registered granted specification is checked. This avoids a false impression that a descriptive chromatography article provides a legal-status opinion.

How to commission a reproducible evidence review

A useful research commission on fatty-acid chromatography has a narrow scope: How should the reported BASF Pharma/Callanish separation-process invention be assessed from claim text and process steps?. The analyst should first establish the evidence relevant to applicant and patent family identity and process inputs and ordered steps, then test separation mechanism and claim scope and dependent variations against competing evidence. Only after those records are compared should the report address status and maintenance and competing process literature. The inquiry should record source identities, dates, assumptions, and contradictory documents. This order matters: a positive finding from one database, a promotional description, or an attractive technical diagram cannot resolve an unknown legal condition. Where the evidence is incomplete, the proper output is an explicit next search or test rather than a confident result.

Evidence register and research deliverables

A practical deliverable for fatty-acid chromatography is a dated source-to-claim or source-to-control register, with one row for each of the six questions above. The first field records the proposition being tested; the second links to the primary evidence, and the third states what alternative explanation has been considered. For this page, the proposed distinctive output is: Process step dependency matrix linked to actual patent claims. A research packet should also record which evidence is missing and who is authorized to make the consequential decision. The source hierarchy should start with IP India prosecution file, then use technical publications and comparable records to interpret—not replace—the primary evidence. The resulting report should make the boundary between historical narrative, observed technical facts, legal interpretation and untested commercial hypotheses plain to readers.

Sources and verification boundaries

The following are authoritative sources or official discovery portals for the relevant methodology. A patent-office search portal is not itself evidence that any named patent currently remains in force. Claims about an individual case require its underlying file.

  • https://ipindia.gov.in/pages/e-services
  • https://patentscope.wipo.int/

Related research

Author and disclaimer

Research editorial draft for GIPResearch.com. The site is an information and research platform. This article is not personalized legal advice, a current patent-register certificate, a freedom-to-operate opinion, or a guarantee of any regulatory or commercial result. Verify material claims with current primary records. Full disclaimer.

Research checklist: what to verify before you decide

Use this checklist to assess the evidence behind basf pharma callanish limited received a patent for multi step separation process rather than relying on a single summary or marketing claim.

  1. Applicant and patent family identity
  2. Process inputs and ordered steps
  3. Separation mechanism
  4. Claim scope and dependent variations
  5. Status and maintenance
  6. Competing process literature
  7. Original analytical framework and decision implications
  8. How to commission a reproducible evidence review

Official sources and research starting points

These are research starting points. Specific factual and legal conclusions require checking the underlying documents and dates.

  1. https://ipindia.gov.in/pages/e-services
  2. https://patentscope.wipo.int/

Featured Work & Insights